Peel Hunt reaffirmed their buy rating on shares of Sinclair Pharma PLC (LON:SPH) in a research note released on Tuesday morning. The firm currently has a GBX 68 ($0.86) target price on the specialty pharmaceutical company’s stock.

Sinclair Pharma PLC (LON:SPH) opened at 33.25 on Tuesday. The firm’s 50 day moving average price is GBX 32.28 and its 200-day moving average price is GBX 31.39. The company’s market capitalization is GBX 166.98 million. Sinclair Pharma PLC has a 12-month low of GBX 26.00 and a 12-month high of GBX 36.75.

ILLEGAL ACTIVITY NOTICE: “Peel Hunt Reiterates Buy Rating for Sinclair Pharma PLC (SPH)” was first posted by Marea Informative and is the sole property of of Marea Informative. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at http://www.mareainformativa.com/sinclair-pharma-plc-sph-dada-la-compra-de-estrellas-en-la-cascara-de-caza/108615/.

About Sinclair Pharma PLC

Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.

Receive News & Stock Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related stocks with our FREE daily email newsletter.